NCT04507763View on ClinicalTrials.gov

Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis

CompletedOBSERVATIONAL
Enrollment

763

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

October 1, 2020

Study Completion Date

October 1, 2020

Conditions
Ankylosing Spondylitis
Interventions
DRUG

Etanercept

Patients with ankylosing spondylitis as provided in real world practice

Trial Locations (1)

Unknown

Pfizer, Baghdad

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT04507763 - Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis | Biotech Hunter | Biotech Hunter